SIGN IN
Executive Director, Disease Area Strategy Lead, Obesity and Related Conditions jobs in United States
cer-icon
Apply on Employer Site
company-logo

Amgen · 21 hours ago

Executive Director, Disease Area Strategy Lead, Obesity and Related Conditions

Amgen is a leading biotechnology company focused on serving patients with serious illnesses. The Executive Director, Disease Area Strategy Lead for Obesity and Related Conditions will be responsible for driving commercial strategy for early-stage innovation, partnering with senior leadership to align research investments with long-term business objectives.
BiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Partnering with Senior Leadership to define Amgen’s early pipeline commercial strategy to ensure investments in research and early development align with long-term business objectives and patient needs within OaR
Partnering closely with R&D, global marketing, and corporate development teams to assess external innovation and business development opportunities, ensuring alignment with Amgen’s portfolio strategy
Supporting portfolio investment decisions in coordination with the Enterprise Portfolio Governance function
Developing commercial frameworks and business cases to inform progression decisions for early-stage assets, integrating insights from market dynamics, patient needs, and competitive intelligence
Building a best-in-class commercial function for early pipeline strategy, ensuring Amgen maintains a leadership position in bringing first-in-class and best-in-class therapies to market
Leverages frameworks for evaluating and prioritizing early-stage assets Assess commercial viability and differentiation of assets in early development, ensuring alignment with evolving market needs and payer landscapes
Shape long-term portfolio strategy in collaboration with R&D, finance, and business development teams
Provide commercial input to research-stage investment decisions, ensuring a clear path to differentiated and commercially viable products
Collaborate with R&D to develop target product profiles (TPPs) that reflect strong commercial positioning
Partner with Amgen’s Business Development team to evaluate in-licensing, partnerships, and acquisitions for early-stage assets
Conduct commercial due diligence on external opportunities, integrating scientific innovation with market insights
Lead the cross functional Therapy Area Strategy group focused on early pipeline and business development
Establish strong cross-functional partnerships with R&D, corporate strategy, finance, and global marketing teams
Play a key role in the Portfolio Governance process, ensuring that commercial insights drive R&D investment decisions
Align early-stage investments with Amgen’s strategic growth objectives and therapeutic area priorities

Qualification

Commercial strategyBiopharmaceutical industry experienceLeadership experienceMarket assessmentBusiness developmentCross-functional collaborationAnalytical skillsFinancial skillsTeam developmentExecutive leadershipStrategic thinking

Required

Doctorate degree & 6 years of commercial experience OR
Master's degree & 10 years of commercial experience OR
Bachelor's degree & 12 years of commercial experience AND
6 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs or directing the allocation of resources
A minimum of 3 years of relevant experience either via a scientific degree or position held in a scientific field

Preferred

Master of Business Administration
MD or PhD in a life sciences-related field (e.g., molecular biology, immunology, pharmacology)
12+ years of commercial experience in the biopharmaceutical industry, with time spent in marketing, commercial strategy, and/or pipeline development
Experience in management consulting (McKinsey, Bain, BCG) focused on strategy, commercial development, and business development in the life sciences industry
Experience in commercial development for pipeline assets, including product positioning, market assessment, and competitive analysis
Experience in business development, including due diligence and partnership evaluations
Experience working in cross-functional leadership roles across commercial and R&D teams
Track record in enterprise portfolio strategy, including investment decision-making and pipeline prioritization
Executive leadership and people management skills with a proven ability to develop and mentor high-performing teams
Prior biopharmaceutical leadership experience overseeing commercial strategy, commercial development, and marketing functions
Deep knowledge of global biopharma market dynamics, payer trends, and competitive landscapes
Experience engaging with executive leadership and board-level stakeholders on commercial and R&D investment decisions
Analytical, financial, and strategic thinking skills with the ability to translate complex data into actionable insights

Benefits

Comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts.
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans and bi-annual company-wide shutdowns
Flexible work models, including remote work arrangements, where possible

Company

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

H1B Sponsorship

Amgen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)

Funding

Current Stage
Public Company
Total Funding
$28.5B
2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO

Leadership Team

leader-logo
Robert Bradway
Chairman and Chief Executive Officer
linkedin
leader-logo
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
linkedin
Company data provided by crunchbase